Global and China Swine Reproductive and Respiratory Syndrome Vaccine Market Insights, Forecast to 2027

Swine reproductive and respiratory syndrome is an acute and highly contagious viral infection characterized by reproductive disorder and respiratory symptoms in pig population.
Boehringer ingelheim is the company with the largest market share, about 25 percent.

Market Analysis and Insights: Global and China Swine Reproductive and Respiratory Syndrome Vaccine Market
This report focuses on global and China Swine Reproductive and Respiratory Syndrome Vaccine market.
In 2020, the global Swine Reproductive and Respiratory Syndrome Vaccine market size was US$ 385.1 million and it is expected to reach US$ 760.2 million by the end of 2027, with a CAGR of 10.2% during 2021-2027. In China the Swine Reproductive and Respiratory Syndrome Vaccine market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Swine Reproductive and Respiratory Syndrome Vaccine Scope and Market Size
Swine Reproductive and Respiratory Syndrome Vaccine market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Swine Reproductive and Respiratory Syndrome Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Swine Reproductive and Respiratory Syndrome Vaccine market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type
Active Vaccine
Inactivated Vaccines
The segment of active vaccine holds a comparatively larger share in global market, which accounts for about 90%.

Segment by Application
Government Tender
Market Sales
The vaccine is fully applicated in market sales.

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
ASCENT CORPORATION
Boehringer-Ingelheim
MSD Animal Health
SPAH
Ceva
Chengdu TECH-BANK Biological Products Co,.Ltd
ringpu
QILU ANIMAL HEALTH PRODUCTS CO.,LTD
DAHUANONG
CAVAC
Komipharm
Agrovet
Bioveta
JINYU BIO-TECNOLOGY CO.,LTD
Phibro Animal Health
ANHUI TIANKANG(GROUP)SHRES O., LTD
Zoetis
WINSUN BIO
PULIKE BIOLOGICAL ENGINERING,INC.